University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > pifeltro

Doravirine (Pifeltro)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."

Approved adult dosing

One 100 mg tablet doravirine (Pifeltro) once daily

  • One tablet once daily



Notes on taking this medication

  • Can take with or without food
  • Doravirine can interact with other drugs; persons using doravirine with those drugs may need an adjustment to their dose of doravirine or may need to avoid certain combinations; consult your medical provider

Possible side effects

  • Diarrhea, nausea
  • Headache
  • Rash (usually is mild to moderate. If severe rash develops, contact your medical provider)

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Scroll over drug name to see other names for the drug.